MIRA Pharmaceuticals' Formulated Shows Greater Efficacy Than FDA-Approved Drug For Chemo ...
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) stock is trading higher on Monday after the company released new preclinical ...
Patient with Guillain-Barre Syndrome treated successfully in Kalaburagi
Manur Multi Specialty Hospital successfully treats 14-year-old boy with Guillain-Barre Syndrome, AMSAN, and breathing issues.
MIRA Pharmaceuticals' Ketamir-2 Shows 60% Greater Efficacy Than FDA-Approved Gabapentin in ...
Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be ...
Complement Inhibitors Clinical Trial Pipeline Analysis: 40+ Key Companies Shaping the ...
The complement inhibitors market is gaining momentum due to the rising recognition of the complement system's role in driving rare and chronic diseases, such as paroxysmal nocturnal hemoglobinuria ...
glasgowlive.co.uk on MSN3 小时
Inspiring Glasgow teen joins Paddy McGuinness on epic Children in Need cycle challenge
The treatment was extensive a stem-cell transplant, immunotherapy, an operation to remove the tumour and chemotherapy. After ...